Elizabeth A. Yamashita is VP at Oncobiologics, Inc. (ONS). They have made 2 open-market trades across 1 company since 2017, most recently 2017-12-22.
CIK 0001663252
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONS | 64,648 | $42K |
Shares reported on the most recent Form 4, priced at the 2017-12-26 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.